Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

607 public trials 71 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Completed

NCT01092741

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +10 more
Locations: The University Of MD Anderson Cancer Center Houston, Texas, United States

Completed

NCT00428909

Conditions: Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations: Novartis Investigative Site Seoul, South Korea

Completed

NCT00750659

Conditions: Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Chronic Disease, +19 more
Locations: Chaim Sheba Medical Center Tel Litwinsky, Israel

Completed

NCT01075425

Conditions: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +22 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

Virginia Commonwealth University Richmond, Virginia, United States

Completed

NCT02733445

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia (CML), +11 more
Locations: Not specified

Completed

NCT01275196

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: Novartis Investigative Site Guangzhou, Guangdong, China

Novartis Investigative Site Guangzhou, Guangdong, China

Novartis Investigative Site Wuhan, Hubei, China

Novartis Investigative Site Chengdu, Sichuan, China

Completed

NCT01043874

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia in Chronic Phase, +12 more
Locations: Novartis Investigative Site Nagoya, Aichi-ken, Japan

Novartis Investigative Site Nagoya, Aichi-ken, Japan

Novartis Investigative Site Nagoya, Aichi-ken, Japan

Novartis Investigative Site Aomori, Japan

View all 20 locations